News
-
smartbax In-Licenses Lead Antibacterial Compound Targeting Gram-Negative Infections from Aicuris
PRESS RELEASE
January 20, 2026
-
Antibiotika-Entwicklung: 4,7 Mio. Pre-Series-A für smartbax – Dr. Robert Macsics
PODCAST [German]
November 20, 2025
-
smartbax Raises €4.7 M in pre-Series A to Advance Development of Antibiotics
PRESS RELEASE
October 22, 2025
-
smartbax moves to the Life Science Factory in Munich
NEWS
September 01, 2025
-
Superbugs vs. Smartbax – Neue Wege in der Antibiotika-Entwicklung mit Smartbax CEO Robert Macsics
PODCAST [German]
February, 02, 2025
-
Neue Antibiotika gegen die Resistenzkrise
ARTICLE [German]
January 23, 2024
-
Seed Financing Round of €1.2M to Develop Antibiotics
PRESS RELEASE
May 23, 2023
Upcoming events
-
GRC: New Antibacterial Discovery and Development
8-13 March 2026
Tuscany, Italy
-
PyCon DE & PyData
13-17 April 2026
Darmstadt, Germany
-
ESCMID Global 2026
17–21 April 2026
Munich, Germany
Past events
-
10th AMR Conference
3-4 March, 2026
Basel, Switzerland
-
HTGF Family Day
19-20 May, 2025
Berlin, Germany
-
Salt’n’Venture
5-6 March, 2025
Salzburg, Austria
-
9th AMR Conference
25-26 February 2025
Basel, Switzerland
-
Prague.bio Conference 2025
24 September, 2024
Prague, Czech Republic
-
ESCMID/ASM conference: Meet the Challenge of Antimicrobial Resistance
17–20 September, 2024
Porto, Portugal -
Falling Walls Science Summit 2023
7-9 November 2023
Berlin, Germany
-
29th annual BIO-Europe
6-8 November, 2023
Munich, Germany
-
Festival of the Future
6-9 July, 2023
Munich, Germany
-
BioVaria
28-29 April, 2023
Munich, Germany
-
8th AMR Conference
6-7 March, 2023
Basel, Switzerland
-
New Antibacterial Discovery and Development | Gordon Research Conference
March 17-22 March, 2024
Ventura, California, United States
-
4th Bacterial Cell Biology Conference
12–15 February 2023
Cancun, Mexico